# Clover Health (CLOV) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/CLOV
## Company Profile
- Ticker: CLOV
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 4.29 USD
- Market cap: 1964532528.52 USD
- Last updated: 2026-09-08
## Business Overview
### Medicare Advantage
Clover Health operates a wide-network Medicare Advantage plan designed to improve access and outcomes for older adults, including populations that have historically lacked affordable, high-quality care.
### Clover Assistant
Its clinical model is powered by Clover Assistant, an AI-enabled software platform that aggregates patient information across the healthcare ecosystem and supports physicians in identifying and managing chronic disease earlier.
### Physician Enablement
Rather than relying on a narrow provider network, Clover supplies participating physicians with data and decision support intended to personalize care and improve clinical outcomes.
### Counterpart Health
Counterpart Health extends Clover's technology beyond members of its own insurance plan. This subsidiary offers the platform to external healthcare providers seeking to improve outcomes and reduce medical costs.
## Why The Stock Is Moving

As of Sep 8, 2026, CLOV closed up 0.82% at $4.29. No new same-company headline was identified in the current news window.

## Recent News
- 2026-08-31 20:05 EST — [Clover Health to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/CLOV/clover-health-to-participate-in-upcoming-investor-conferences-4d97ee68) — Source: Clover Health
- 2026-08-05 20:05 EST — [Clover Health Reports Second Quarter 2026 Results](https://biopharmsignal.com/news/CLOV/clover-health-reports-second-quarter-2026-results-0e38ca76) — Source: Clover Health
- 2026-07-22 20:05 EST — [Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference](https://biopharmsignal.com/news/CLOV/clover-health-to-participate-in-upcoming-canaccord-genuity-46th-annual-growth-co-ed8fb164) — Source: Clover Health
- 2026-07-09 20:05 EST — [Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026](https://biopharmsignal.com/news/CLOV/clover-health-to-report-second-quarter-2026-financial-results-on-august-5-2026-53f0271f) — Source: Clover Health
- 2026-07-07 12:30 EST — [Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up](https://biopharmsignal.com/news/CLOV/clinical-excellence-in-continuity-of-care-counterpart-assistant-ca-use-associate-c70791e1) — Source: Clover Health